Content about Dow Jones

August 23, 2012

Kraft to sell majority stake in natural-food brand to Brynwood Partners

Confectionary, food and beverage conglomerate Kraft Foods is selling part of its natural-food products line, Back to Nature, to private-equity firm Brynwood Partners.

Confectionary, food and beverage conglomerate Kraft Foods is selling part of its natural food products line, Back to Nature, to private-equity firm Brynwood Partners.

While Kraft has sold two other brands to Brynwood, it’s keeping a minority stake — reported to be between a quarter and a half, according to Dow Jones— in the Back to Nature line, which currently includes crackers, cookies, granola and trail mixes that contain less-processed ingredients.

October 19, 2011

Heavy  hITters

How many times have we heard it said that one day in America there will be a nationwide health information network that will link patients, providers and payers seamlessly, efficiently and securely, across a universal standardized system? It’s been the dream of health information technology strategists and engineers for decades. And yet, when you take a look at the healthcare experience of the typical American consumer, you’d be hard-pressed to find evidence that we are any closer to achieving that dream today than we were in the days of the Carter administration. 

October 11, 2011

Lupin launches contraceptive authorized generic

Indian generic drug maker Lupin has launched an authorized generic version of a birth control pill made by Warner Chilcott, according to published reports.

NEW YORK — Indian generic drug maker Lupin has launched an authorized generic version of a birth control pill made by Warner Chilcott, according to published reports.

Dow Jones reported that Lupin launched an authorized generic of Femcon (norethindrone and ethinyl estradiol tablets, ferrous fumarate tablets).

An authorized generic is a branded drug sold under its generic name at a reduced price, usually through a third-party company.

April 13, 2011

Report: Target puts Canadian sales at $6 billion by 2017

Target expects sales from its upcoming Canadian stores to total more than $6 billion by 2017, Dow Jones reported.

NEW YORK — Target expects sales from its upcoming Canadian stores to total more than $6 billion by 2017, Dow Jones reported.

Speaking to Wall Street analysts, CFO Douglas Scovanner said Tuesday that Target expects to have more than 200 stores in Canada within the next five to 10 years, with the stores generating about $6 billion Canadian ($6.27 billion in U.S. dollars based on Tuesday’s exchange rate).

Target’s initial group of stores will open through the chain’s purchase in January of up to 220 leases held by Hudson's Bay Co.'s Zellers stores.

November 9, 2010

Report: Cessation programs fall by the wayside

According to a recently published Dow Jones report, state-funded tobacco-prevention programs quickly are becoming the...

NEW YORK According to a recently published Dow Jones report, state-funded tobacco-prevention programs quickly are becoming the latest casualty of constricting state budgets, prompting concern among public health groups around the nation's progress toward getting adult smokers to quit.

The number of adults who smoke has remained relatively steady since 2004 — 20.6% of the population were smokers in 2009.

April 8, 2010

Report: Take Care Health Systems seeks joint ventures with hospitals

In an effort to further expand its retail-based clinic business, Walgreens' Take Care Health Systems...

NEW YORK In an effort to further expand its retail-based clinic business, Walgreens' Take Care Health Systems reportedly is considering financial joint ventures with hospitals, according to a Dow Jones Newswires report.

"We're getting a lot of interest from hospital systems," Take Care Health Systems CEO Peter Miller told Down Jones Newswires in an interview.